We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

78 hedge funds and large institutions have $56.5M invested in Spectrum Pharmaceuticals Inc in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $611K | Put options by funds: $153K

82% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 11

69% more capital invested

Capital invested by funds: $33.4M → $56.5M (+$23M)

13% more funds holding

Funds holding: 69 → 78 (+9)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

Holders
78
Holders Change
+9
Holders Change %
+13.04%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
13
Reduced
21
Closed
11
Calls
$611K
Puts
$153K
Net Calls
+$458K
Net Calls Change
+$114K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$4.82M
2
AC
Armistice Capital
New York
+$3.26M
3
E
Ergoteles
New York
+$2.3M
4
NYLIM
New York Life Investment Management
New York
+$1.36M
5
CM
Crystalline Management
Canada
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$797K
2
Millennium Management
Millennium Management
New York
-$333K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$195K
4
Bank of America
Bank of America
North Carolina
-$194K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$162K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
$18.3K -$316 -320 -2%
Creative Planning
52
Creative Planning
Kansas
$15.8K – – –
Lido Advisors
53
Lido Advisors
California
$14.4K +$14.8K +15,000 New
CWA
54
CM Wealth Advisors
Ohio
$14.3K +$13.7K +13,890 New
PA
55
Parallel Advisors
California
$13.4K – – –
Fidelity Investments
56
Fidelity Investments
Massachusetts
$12.4K +$8.08K +8,178 +172%
Simplex Trading
57
Simplex Trading
Illinois
$12K +$12.4K +12,547 New
FIA
58
Foundations Investment Advisors
Arizona
$9.6K +$3 +3 +0%
AWM
59
Arista Wealth Management
Nevada
$9.6K – – –
MWM
60
Mission Wealth Management
California
$9.6K – – –
NFC
61
Northeast Financial Consultants
Connecticut
$9.6K – – –
NAS
62
NWF Advisory Services
California
$9.6K – – –
TWM
63
Tradition Wealth Management
Minnesota
$5K – – –
JP Morgan Chase
64
JP Morgan Chase
New York
$3.77K – – –
UBS Group
65
UBS Group
Switzerland
$3.58K +$318 +322 +9%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$3.46K +$3.56K +3,600 New
KFI
67
Key Financial Inc
Pennsylvania
$2.4K – – –
SPIA
68
Steward Partners Investment Advisory
New York
$2.16K – – –
TRCT
69
Tower Research Capital (TRC)
New York
$1.69K +$1.69K +1,709 +3,418%
FDCDDQ
70
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.54K – – –
AF
71
Allworth Financial
California
$1.33K – – –
FWM
72
Focused Wealth Management
New York
$768 – – –
UB
73
UMB Bank
Missouri
$192 – – –
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
$177 +$155 +157 +581%
Citadel Advisors
75
Citadel Advisors
Florida
$96 +$99 +100 New
1 2
3
4

SPPI Hedge Fund Activity: Q2 2023 in Review

78 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2023, worth a combined $56.5M — up 69% from $33.4M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new SPPI positions and 11 closed out — a net gain of 9 holders — while 13 added to existing stakes and 21 trimmed.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $4.82M. The largest seller was Acadian Asset Management, cutting an estimated $797K.

  • 78 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2023, up from 69 in Q1 2023.
  • Funds reported $56.5M of Spectrum Pharmaceuticals Inc stock for Q2 2023, up 69% quarter-over-quarter.
  • 20 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2023 and 11 closed out, a net change of +9 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2023 was Kennedy Capital Management, an estimated $4.82M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2023 was Acadian Asset Management, an estimated $797K sold.

Based on aggregated 13F filings for Q2 2023.